Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials
- 1 August 2015
- journal article
- review article
- Published by Elsevier BV in International Journal of Oral & Maxillofacial Surgery
- Vol. 44 (8), 1018-1026
- https://doi.org/10.1016/j.ijom.2015.04.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: A randomized, controlled, double-blind multicenter studyPain, 2011
- Effect of Botulinum Toxin-A in Myofascial Pain Patients With or Without Functional Disc DisplacementJournal of Oral and Maxillofacial Surgery, 2008
- The emerging role of botulinum toxin in the treatment of temporomandibular disordersOral Diseases, 2007
- A Critical Review of the Use of Botulinum Toxin in Orofacial Pain DisordersDental Clinics of North America, 2007
- Botulinum Toxin for the Treatment of Temporomandibular Joint Disk Disfigurement: Clinical ExperienceThe Journal of Craniofacial Surgery, 2005
- HYPOTHESIS ON A CAUSE OF TEMPOROMANDIBULAR JOINT DISORDERSPlastic and Reconstructive Surgery, 2003
- Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effectsExpert Opinion on Investigational Drugs, 2001
- Regular review: Uses of botulinum toxin injection in medicine todayBMJ, 2000
- Botulinum toxin in the treatment of myofascial pain syndromePain, 1994